Evidence map›Paper›PMID 28938420›Full record

ArticleThe Journal of clinical endocrinology and metabolism2017

Bone Structural Characteristics and Response to Bisphosphonate Treatment in Children With Hajdu-Cheney Syndrome.

Sophia Sakka, Rachel I Gafni, Justin H Davies, Bart Clarke, Peter Tebben, Mark Samuels, Vrinda Saraff, Klaus Klaushofer, Nadja Fratzl-Zelman, Paul Roschger and 2 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Hajdu-Cheney Syndrome: A Systematic Review of the Literature.International journal of environmental research and public health · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nursing Care Plan for Patients with Hajdu-Cheney Syndrome.International journal of environmental research and public health · 2022
    Article
  8. Hajdu-Cheney Syndrome: Report of a Case in Spain.Diagnostics (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Oral Surgery Procedures in a Patient with Hajdu-Cheney Syndrome Treated with Denosumab-A Rare Case Report.International journal of environmental research and public health · 2021
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Antisense oligonucleotides targetingThe Journal of biological chemistry · 2020
    Article
  17. Article
  18. Notch in skeletal physiology and disease.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 4 countries.

Sophia SakkaDepartment of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham B4 6NH, United Kingdom.
Rachel I GafniSection on Skeletal Disorders and Mineral Homeostasis, NIDCR, National Institutes of Health, Bethesda, Maryland 20892.
Justin H DaviesDepartment of Endocrinology, Southampton Children's Hospital, Southampton SO16 6YD, United Kingdom.
Bart ClarkeDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Peter TebbenDepartment of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Mark SamuelsCentre de Recherché du Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal H3T 1C5, Canada.
Vrinda SaraffDepartment of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham B4 6NH, United Kingdom.
Klaus KlaushoferLudwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK, 1140 Vienna, Austria.
Nadja Fratzl-ZelmanLudwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK, 1140 Vienna, Austria.
Paul RoschgerLudwig Boltzmann Institute of Osteology at Hanusch Hospital of WGKK, 1140 Vienna, Austria.
Frank RauchShriners Hospital for Children and McGill University, Montreal, Quebec H4A 0A9, Canada.
Wolfgang HöglerDepartment of Endocrinology and Diabetes, Birmingham Children's Hospital, Birmingham B4 6NH, United Kingdom.
Birmingham Children's Hospital · GBLudwig Boltzmann Institute of Osteology · ATMayo Clinic · USHanusch Hospital · ATMontreal Children's Hospital · CANational Institute of Dental and Craniofacial Research · USSouthampton Children's Hospital · GBUniversité de Montréal · CAUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Hajdu-Cheney syndrome (HJCYS) is a rare, multisystem bone disease caused by heterozygous mutations in the NOTCH2 gene. Histomorphometric and bone ultrastructural analyses in children have not been reported and sparse evidence exists on response to bisphosphonate (BP) therapy. Objective: To investigate clinical and bone histomorphometric characteristics, bone matrix mineralization, and the response of bone geometry and density to BP therapy. Patients: Five children with HJCYS (three males) between 6.7 and 15.3 years of age. Interventions: Various BP regimens (pamidronate, zoledronic acid, and alendronate) were used for between 1 and 10 years. Main Outcome Measures: Pretreatment transiliac bone biopsy specimens and peripheral quantitative computed tomography results were available in four and three subjects, respectively. Bone histomorphometry and quantitative backscattered electron imaging were performed in two patients. The response to BP was monitored using dual-energy X-ray absorptiometry and peripheral quantitative computed tomography. Results: Three patients had previously unreported NOTCH2 mutations. Histomorphometry demonstrated increased bone resorption and osteoclast numbers, increased heterogeneity of mineralization, and immature, woven bone. Trabecular bone formation was normal or elevated. Radius cortical thickness and density and lumbar spine bone mineral density were reduced at baseline and increased in response to BP therapy, which was not sustained after therapy discontinuation. Conclusions: Increased bone resorption and low cortical thickness are consistent with the effect of activating NOTCH2 mutations, which stimulate osteoclastogenesis. The increase in lumbar spine bone density and radial cortical thickness and density by BP therapy provides evidence of beneficial treatment effects in children with HJCYS.

Indexed as

AdolescentAlendronateBone and BonesBone DensityBone Density Conservation AgentsCalcification, PhysiologicCase-Control StudiesChildDiphosphonatesFemaleHajdu-Cheney SyndromeHumansImidazolesMaleMutationOsteoclastsAlendronateBone Density Conservation AgentsDiphosphonatesImidazolesNOTCH2 protein, humanReceptor, Notch2Zoledronic Acid

Identifiers

PMID28938420
PMCPMC5673271
OpenAlexW2179817751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.